Melanoma trials in Georgia

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

  Where

  Batumi, Kutaisi, Tbilisi

  Age

  18 years and over

  People

  120 worldwide

  Run by

  Biocon Biologics UK PLC

  See details and how to joinNCT07476326 · EU 2025-525158-20-00
• Phase 3Taking people
  Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

  Where

  Batumi, Tbilisi

  Age

  18 years and over

  People

  632 worldwide

  Run by

  mAbxience Research S.L.

  See details and how to joinNCT07221734